The clear path to small molecule visualization & quantification

Our team

[vc_row el_class=”container” css=”.vc_custom_1647276081098{margin-top: 80px !important;margin-bottom: 40px !important;}”][vc_column][vc_column_text]We are a collective of passionate and eclectic immunologists and scientists coming together to unlock new possibilities in research, diagnostics and therapy through small molecule antibodies development.

 [/vc_column_text][/vc_column][/vc_row][vc_row el_class=”container”][vc_column][vc_column_text css=”.vc_custom_1653296976063{margin-top: 20px !important;margin-bottom: 10px !important;}”]

Executive team

[/vc_column_text][vc_separator color=”custom” border_width=”2″ accent_color=”#5092d0″][vc_row_inner css=”.vc_custom_1647352767992{margin-top: 40px !important;}”][vc_column_inner width=”2/12″][vc_single_image image=”1858″ img_size=”full”][/vc_column_inner][vc_column_inner width=”4/12″][vc_column_text]Alban Bessede, PhD Founder,
Chief Executive Officer

Born and bred in Bordeaux, Alban founded Immusmol immediately after a post-doc in Sydney. Trained in immunology, he gained expertise in small molecule antibodies doing research in oncology and neurodegeneration. This experience eventually led him to envisage their use in diagnostics and therapy.

    [/vc_column_text][/vc_column_inner][vc_column_inner width=”2/12″][vc_single_image image=”1859″ img_size=”full”][/vc_column_inner][vc_column_inner width=”4/12″][vc_column_text]Dominique Bodet, PhD
Study Director

Over his career, Dominique developed over 70 small molecule antibodies. Initially trained in biochemistry and immunology, he has overseen all Immusmol lab operations, from antigen design to in vivo studies, since the company inception in 2012.

[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”container” css=”.vc_custom_1647276436343{margin-top: 40px !important;margin-bottom: 40px !important;}”][vc_column][vc_column_text css=”.vc_custom_1647275958676{margin-top: 20px !important;margin-bottom: 10px !important;}”]

Board of directors

[/vc_column_text][vc_separator color=”custom” border_width=”2″ accent_color=”#5092d0″][vc_row_inner css=”.vc_custom_1647352767992{margin-top: 40px !important;}”][vc_column_inner width=”2/12″][vc_single_image image=”1862″ img_size=”full”][/vc_column_inner][vc_column_inner width=”4/12″][vc_column_text]Vincent Picq, MSc
Founder, Chairman of Schiever

Vincent Picq has been supporting Immusmol since the very beginning. At the head of a retailing group with annual sales exceeding €1.3 billion, he provides Immusmol with strategic, management, and administrative support.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”2/12″][/vc_column_inner][vc_column_inner width=”4/12″][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]

Hormones

Neurotransmitters

Catecholamines

Tryptophan

Arginine

Amino acids

Antibodies

Support

About us